Mirae Asset Global Investments
TRVI icon

Mirae Asset Global Investments’s Trevi Therapeutics TRVI Stock Holding History

Mirae Asset Global Investments’s Portfolio TRVI Stock Details TRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$118K Sell
6,350
-338
-5% -$4.92K ﹤0.01% 1206
2026
Q1 		$79.8K Buy
6,688
+457
+7% +$5.12K ﹤0.01% 1214
2025
Q4 		$78K Buy
6,231
+1,523
+32% +$17.6K ﹤0.01% 1304
2025
Q3 		$43.1K Buy
4,708
+778
+20% +$5.83K ﹤0.01% 1375
2025
Q2 		$21.5K Buy
3,930
+1,028
+35% +$6.4K ﹤0.01% 1392
2025
Q1 		$18.9K Buy
2,902
+341
+13% +$1.63K ﹤0.01% 1393
2024
Q4 		$10.9K Buy
+2,561
New +$8.2K ﹤0.01% 1506

Other funds holding TRVI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Mirae Asset Global Investments's TRVI Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Trevi Therapeutics (TRVI) stake by 5.1% in Q2 2026, selling an estimated $4.92K and leaving 6,350 shares worth $118K. The position accounts for ﹤0.01% of the portfolio, ranked #1206.

Mirae Asset Global Investments first reported a position in TRVI in Q4 2024 and has held it in 7 quarters since. 69 funds tracked by Wall St. Rank hold TRVI as of Q2 2026.

  • Mirae Asset Global Investments held 6,350 shares of Trevi Therapeutics worth $118K as of Q2 2026.
  • Mirae Asset Global Investments sold 338 Trevi Therapeutics shares in Q2 2026, an estimated $4.92K.
  • Trevi Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1206 holding.
  • Mirae Asset Global Investments first reported a position in Trevi Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 69 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.